As of 2024-12-14, the Intrinsic Value of PRA Health Sciences Inc (PRAH) is
48.94 USD. This PRAH valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 165.21 USD, the upside of PRA Health Sciences Inc is
-70.40%.
The range of the Intrinsic Value is 36.67 - 71.17 USD
48.94 USD
Intrinsic Value
PRAH Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
36.67 - 71.17 |
48.94 |
-70.4% |
| DCF (Growth 10y) |
53.46 - 102.70 |
70.98 |
-57.0% |
| DCF (EBITDA 5y) |
78.55 - 97.30 |
85.16 |
-48.5% |
| DCF (EBITDA 10y) |
88.89 - 123.15 |
102.26 |
-38.1% |
| Fair Value |
14.09 - 14.09 |
14.09 |
-91.47% |
| P/E |
69.63 - 105.65 |
86.50 |
-47.6% |
| EV/EBITDA |
72.70 - 95.71 |
80.92 |
-51.0% |
| EPV |
50.27 - 80.92 |
65.59 |
-60.3% |
| DDM - Stable |
22.95 - 53.82 |
38.39 |
-76.8% |
| DDM - Multi |
30.16 - 58.48 |
40.14 |
-75.7% |
PRAH Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
10,704.85 |
| Beta |
1.31 |
| Outstanding shares (mil) |
64.80 |
| Enterprise Value (mil) |
11,283.55 |
| Market risk premium |
4.24% |
| Cost of Equity |
8.28% |
| Cost of Debt |
4.32% |
| WACC |
7.73% |